Anti-mouse integrin α5β1 antibody inhibits tumor growth
Author Information
Author(s): Bhaskar Vinay, Zhang Dong, Fox Melvin, Seto Pui, Wong Melanie HL, Wales Pauline E, Powers David, Chao Debra T, DuBridge Robert B, Ramakrishnan Vanitha
Primary Institution: Department of Research, PDL Biopharma, Inc.
Hypothesis
Does blocking integrin α5β1 inhibit angiogenesis and tumor growth in mouse models?
Conclusion
The study shows that the antibody 339.1 effectively inhibits angiogenesis and slows tumor growth in vivo.
Supporting Evidence
- Antibody 339.1 inhibited tumor growth by 40-60% in multiple xenograft models.
- The affinity of antibody 339.1 for mouse integrin α5β1 was determined to be 0.59 nM.
- 339.1 induced significant apoptosis in primary mouse endothelial cells.
Takeaway
Scientists created a special antibody that stops tumors from growing by blocking a protein that helps blood vessels form.
Methodology
The study involved generating and testing a panel of rat-anti-mouse α5β1 antibodies in various in vitro and in vivo models.
Limitations
The study primarily focuses on mouse models, which may not fully represent human responses.
Participant Demographics
Female Sprague-Dawley rats were used for antibody generation, and ICR SCID or SCID-Beige mice were used for in vivo studies.
Statistical Information
P-Value
p < 0.05
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website